Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

2008 Lasker Awards Announced

Winners work in microRNA, statins, and antibiotic resistance

by Celia Henry Arnaud
September 16, 2008

Ambros
[+]Enlarge
Credit: Lasker Foundation
Credit: Lasker Foundation

Five international scientists will receive the 2008 Lasker Awards, given by the Albert & Mary Lasker Foundation, at a ceremony on Sept. 26 in New York City.

Baulcombe
[+]Enlarge
Credit: Lasker Foundation
Credit: Lasker Foundation
Ruvkun
[+]Enlarge
Credit: Lasker Foundation
Credit: Lasker Foundation
Endo
[+]Enlarge
Credit: Lasker Foundation
Credit: Lasker Foundation
Falkow
[+]Enlarge
Credit: Lasker Foundation
Credit: Lasker Foundation

Each award carries a $300,000 honorarium, shared equally among the recipients of each award, and an inscribed statuette of the Winged Victory of Samothrace. In the past two decades, 27 Lasker Award recipients have subsequently received a Nobel Prize.

Victor R. Ambros, 54, at the University of Massachusetts Medical School, in Worcester; David C. Baulcombe, 56, at the University of Cambridge; and Gary B. Ruvkun, 56, of Massachusetts General Hospital and Harvard Medical School, will share the Lasker Award for Basic Medical Research for their roles in the discovery of microRNAs, which are small RNA molecules that regulate gene function. Initially discovered in worms, microRNAs have subsequently been found in many other types of organisms. These molecules revealed an unanticipated role for RNA that is being explored for therapeutic applications.

The Lasker-DeBakey Award for Clinical Medical Research honors Akira Endo, 74, of Biopharm Research Laboratories, in Tokyo, for the discovery of mevastatin, also called compactin, the first compound in the class of drugs known as statins. Statins reduce the levels of "bad" cholesterol (low-density lipoprotein) in blood without affecting the levels of "good" cholesterol (high-density lipoprotein). Endo showed in 1979 that mevastatin lowers blood cholesterol in dogs and monkeys. Because of side effects, mevastatin has never been used clinically, but its discovery helped lead to safer cholesterol-control agents.

Stanley Falkow, 74, a microbiologist at the Stanford University School of Medicine, will receive the biennial Lasker-Koshland Award for Special Achievement in Medical Science. The lifetime achievement award honors his contributions to the understanding of disease-causing microbes, particularly in the area of antibiotic resistance.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.